AbbVie (ABBV)
(Delayed Data from NYSE)
$164.66 USD
+0.41 (0.25%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $164.97 +0.31 (0.19%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/26/2024
Time: BMO |
3/2024 | $2.26 | 0.00% |
Earnings Summary
For their last quarter, AbbVie (ABBV) reported earnings of $2.79 per share, beating the Zacks Consensus Estimate of $2.76 per share. This reflects a positive earnings surprise of 1.09%. Look out for ABBV's next earnings release on April 26, 2024. For the next earning release, we expect the company to report earnings of $2.26 per share, reflecting a year-over-year decrease of 8.13%.
Earnings History
Price & Consensus
Zacks News for ABBV
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
ABBV: What are Zacks experts saying now?
Zacks Private Portfolio Services